Welcome, Guest. Please login or register.

Show Posts

This section allows you to view all posts made by this member. Note that you can only see posts made in areas you currently have access to.


Topics - zantriocom

Pages: [1]
1
Zantrio.com Free Daily Stock Picks for Mar 10, 09

(CASY) - buy
Reports Q3 (Jan) earnings of $0.28 per share, $0.09 better than the First Call consensus of $0.19; revenues fell 26.5% year/year to $848.8 mln vs the $961.5 mln consensus.

(AZM) - short
The European Growth and Jobs Monitor, shows the recession affecting all European countries in the course of 2008, with Ireland faring second worst after Italy. Germany fell faster than the average in 2008 sliding from eighth to ninth place.

(JCI) - short
Automotive and business systems maker Johnson Controls said after the bell that it plans to raise $500.0 million in an equity unit offering, leading shareholders to exit the company's stock after the bell Monday.

(AVAV) - short
AeroVironment Inc, a maker of unmanned aircraft systems, posted a 24 percent drop in quarterly profit, trailing market estimates, on higher expenses, and it lowered its full year revenue growth forecast, sending its shares down 29 percent.

(IPCR) - short
After quarterly data released on Friday, with a report of a loss of over $91K from Q3 2008 compared to gains of $43K, $82K and $162K over previous three quarters, a lower trend is all but inevitable.

-------

Sign up and get instant entry alerts for the Free Daily Stock Picks at Zantrio.com.

2
(GERN) - buy
Obama will lift stem cell research funding ban on Monday.

(STEM) - buy
Obama will lift stem cell research funding ban on Monday.

(CYTX) - buy
Obama will lift stem cell research funding ban on Monday.

(CUR) - buy
Obama will lift stem cell research funding ban on Monday.

(ASTM) - buy
Obama will lift stem cell research funding ban on Monday.

Get instant entry alerts for the Free Daily Stock Picks at Zantrio:
http://zantrio.com/stock_picks.php

Detailed performance on the Free Daily Stock Picks at Zantrio:
http://zantrio.com/stock_picks_performance.php

3
(COO) - buy
Cooper, fiscal 1Q profit surges. Company earned $23.9 mln, or 53 cents per share, for the quarter ended Jan. 31, compared with net income of $6.9 mln, or 15 cents per share, during the same period a year prior.

(ARST) - buy
ArcSight, Q3 profit beats Street, sees strong Q4. Co issues upside guidance for FY09, sees EPS of $0.41-0.48 vs. $0.29 consensus; sees FY09 revs of $130.9-134.9 vs. $127.34 mln consensus.

(IPI) - short
Intrepid Potash, earnings preview. IPI has a short history as the IPO was issued in April of 2008. Since then, the co missed by $0.07 in the most recent quarter (Q3). The current quarter provides more uncertainty following the reduction in sales by 50%.

(EBS) - short
Emergent BioSolutions, 4Q profit plunges. Company set its revenue outlook well below Wall Street forecasts.

(SEPR) - short
Sepracor, reports preliminary Phase II study results for SEP-225441 for the treatment of generalized anxiety disorder, did not meet its primary efficacy endpoint.

4
(WTW) - buy
Weight Watchers Q4 profit beats estimates. Co reported a fourth-quarter net income of $47.6 mln, or 62 cents per share, compared with $39.8 mln, or 50 cents per share, a year ago.

(SIGM) - buy
Sigma Designs profit tops estimates. Co Q4 adj EPS was $0.38 vs est $0.18.

(PETM) - buy
PetSmart Inc. said that its fourth-quarter profit rose to $78.4 mln, or 62 cents a share, from $75.4 mln, or 59 cents a share, in the year-ago period. Revenue rose to $1.36 bln from $1.33 bln last year.

(GYMB) - short
Gymboree gives bleak Q1 outlook. Co issues downside guidance for Q1, sees EPS of $0.18-0.25 vs. $0.76 consensus.

(FPIC) - short
FPIC Insurance reports Q4 net income per share of $0.55 vs $1.17 First Call consensus.

5
(GB) - buy
Wilson Greatbatch beats by $0.13, beats on revs; guides FY09 revs in-line.

(MASI) - buy
Masimo Q4 results top estimates. Total revenue rose 20 percent to $83.1 million.

(DEO) - short
Diageo plc to cut 4% of North American workers - WSJ

(PALM) - short
Palm Inc warned of weaker-than-expected quarterly revenue due to lower demand for its older phones, a weak economy and late U.S. shipments of its Treo Pro.

(URS) - short
URS gives weak outlook. Co also issues mixed guidance for FY09, sees EPS of $2.80 vs. $2.95 consensus; sees FY09 revs of $9.5 bln vs. $10.35 bln consensus.

6
(ACL) - buy
Alcon, Inc, the world’s leader in eye care and cataract surgery announced that the U.S. Food and Drug Administration (FDA) approved its aspheric AcrySof® IQ Toric intraocular lens (IOL).

(SYKE) - short
Sykes Enterprises 4Q profit drops 19 percent. Co issues downside guidance for Q1, sees EPS of $0.28-0.30 vs. $0.32 consensus; sees Q1 revs of $203 mln vs. $205.86 mln consensus.

(MDR) - short
McDermott 4th-qtr profit down sharply. Fourth-quarter profit fell to $43 mln, or 19 cents per share, from $160 mln, or 70 cents per share, a year before.

(GENZ) - short
Genzyme's Lumizyme faces delay after FDA rejection.

(FELE) - short
Franklin Electric posts lower-than-expected Q4 results.

7
(WGOV) - short
Woodward Governor cuts 2009 outlook. Co lowers FY09 EPS to $1.40-1.65, vs $1.75 First Call consensus. Co also lowers FY09 revs to $1.3 bln vs $1.46 bln First Call consensus.

(HMC) - short
Honda Motor Co, to cut output at home by over 150,000 units in the year from April, bringing its Japanese production below 1 million vehicles for the first time in 14 years.

(DVA) - short
DaVita discloses that it is the subject of a number of inquiries by the federal government. Any negative findings could result in substantial financial penalties, exclusion from future participation in the Medicare programs and, criminal penalties.

(RRD) - short
Standard & Poor's Ratings Services said it is considering downgrading ratings for R.R. Donnelley & Sons Co., based on fears about the company's performance in 2009 through the economic downturn.

(HBC) - short
HSBC Holdings is going to announce plans Monday to raise at least ($17.18 billion) in fresh capital and cut its dividend, according to people familiar with the situation. Even banks that have until now remained healthy are getting hit by the global downturn.

Pages: [1]